Extramedullaryplasmacytoma isa rareplasmacellproliferativedisorder with a predilection for the head and neck region. Occasionally, it presents as a solitary lesion in the nasal cavity. We report a case of an isolated lesion in the middle turbinate of the right nasal cavity. The lesion was completely excised via an endoscopic approach. We also reviewthepathology and management of plasmacytomas in general. -DAY COURSE DESCRIPTION : This course is a comp rehensive overv iew of the newly emergi ng fi eld of endoscopic skull base surgery combin ing didactic sessions with hands-on cadaver dissection. At the completion of this cou rse, part icipants should be well equipped to start ut ilizing t hese appro aches in th eir own pract ices. Endoscopic int st rument s and surgical navigati on equipme nt will be available to part icipan ts for use on fresh cadavers du ring labor atory sessions. Pa rt icipant s will have an oppo rt unity to discuss diffic ult cases w it h th e faculty during panel discussions. Early registrati on is highly recommended.
Introduction
The term plasma cell tumorencompasses tumors along a clinical spec tru m th at includes multiple myeloma and plasm acytoma. The latt er can be subclassified as solitary or extramedullary; solitary plasm acytoma app ears in bone (prim arily the lon g bones), and extram edullary plasm acytoma appears in soft tissue .
Neoplastic proliferation of plasma cells characterized by marked proteinuria and bone pain was described sepa rately in 1846 by both Dalrymple' and Bence Iones.' Von Rustizky in Kiev coin ed the term multiple myeloma in 1873. 3 In 1905, Schridd e bec am e th e first to report a case of extram ed ullary plasm acytoma. ' Plasm acytomas are rare. They represent th e manifestation of a plasma cell proliferative disorder. They are related to multiple myelomas in th e sense th at both of th ese condition s ar ise as a result of monoclon al proliferation of plasm a cells th at produce a single homogenous immunoglobulin m olecule or frag me nt . Th e prim ary difference between the two conditions is that plasmacytomamanifests as a solitary tumor,wh ereas multiple myeloma, as th e name suggests, can involve multiple organ systems .Also, multiple myeloma is essentially incurable and carries a poorer prognosis.' Solitar y plasmacytoma ofbone is some times an early sign of multiple myeloma, and it is mo re likely th an extramedullar y plasmacytoma to evolve into disseminated multiple myeloma.
Extramedullary plasma cytoma arises from extramedullaryprogenito r cells th at later differentiate into submucosal plasm a cells. Extram edull ary plasm acytoma may remai n localized or even disseminated, but it is distinct from multiple myeloma in that its dissemination pattern is different an d its pro gnosi s is better.
Extramedullary plasmacytoma tends to occur in the sixth and seventh decades of life, and it is three to four times more common in men th an in women."Although it has a predilection for th e head and neck region, extr am edullaryplasmacytoma accounts for less than 1% of all head and neck cancers.' Almo st 80% of extramedullary plasm acytomas occur in the subm ucosal tissues in th e head and neck"; 10 to 20% of th ese m ay present as multiple lesions." The m ost comm on locations are the nasopharynx and th e paranasal sinus es; others havebeen repo rte d in the orophar ynx, larynx, tongue, minor salivar y glands, thyroid, orb it, skull base, and mastoid.v" :" Location s outside th e head and neck include the pleura, me diastinum, sperm atic cord, ovary, intestines, kidney, pan creas, bre asts, and skin . In this article, we report a new case of extrame dullary plasm acytoma in which a solitar y lesion arose in the nasal cavity.
Case report
A 54-year-old man presented with a 5-month history of epistaxis from the right no stril. His episodes of bleeding were intermittent and self-limiting, and he lost ap - proximately Sto 10mlofblood during each occurrence. Approximately 1 month after the onset of the epist axis, he began to experience right-sided nasal blockage and hypo smia. He reported no other associated symptoms, and he had no other medical conditions.
Examination of the no se revealed the pre sence of a smooth, bulbous mass in th e right nasal cavity. Th e mass was attached to th e anterior on e-third of the right middle turbinate. The covering muco sa appeared to be normal and in continuity with th e middle turbinate. The rest of the nasal cavity and nasopharynx appeared to be normal. There were no palpab le lymph nodes. Computed tomography (CT) of th e paranasal sinuses demonstrated the smooth, spherical lesion arising from the right middle turbinate and obstructing the right ostiomeatal complex (figure 1).CT also showed mucosal thickening of the left maxillary and frontal sinuses.
An endoscope-assisted excision biop syof the m asswas performed. An intraoperative examination confirmed that the mass was smooth and spherical and that it had arisen from the anterior end of the right middle turbinate. It was firm and nonmobile. The mucosa appeared to be normal, as did the rest of th e nasal cavity and nasopharynx. The mass was excised and sent for histop athologic examination . A Merocel nasal pack was inserted for 24 hours. The patient was discharged in good condition .
Thehistop atholo gic examination revealed fragmented polypoidal structures made up ofcongested stroma that was den sely infiltrated by sheets ofovoid neoplastic cells Volume 88, Number 2 with eccentric hyperchromatic pleomorphic nuclei and occasional prominent nucleoli (figure 2). Some tumor cellswere bin ucleated and trinucieated.Aberrant mitoses were also noted. The histomorphology of these tumor cells closely resembled that of plasma cells. Immunohistochemistry was performed,and the tumor cellsshowed negative expression for MNFl16, L26, and CD4SRO (UCH LI). Staining for kappa and lambda light chain s was inconclusive. In all, th ese features were suggestive of a plasmacytoma.
The patient underwent a complete blood count, bo ne marrow biopsy, urine and serum electrophoresis, and serum bioc hemistry (including measurements of calcium, blood urea nitrogen, creatinine, uric acid, and protein), and all results were found to be normal. Likewise, an immunoglobulin assay, CA12S measurement, and magnetic reson ance imaging (MRI) from the skull base to th e iliac crest were also normal. Based on the totality ofthese findings,weconcluded that the lesion was a solitary on e and th at it had been completely removed. The pat ient remained well during follow-up.
Discussion
The diagnosis of extramedullary plasm acytoma requires a histopathologic examination of resected specime ns aided by immunohistochemical staining. Fine-needle aspiration cytolog y is not diagno stic because it usually does not yield sufficient material for detailed immunohistochemistr y. A definiti ve diagno sis usuall y requires a larger tissue sample obt ained in the form of a biopsy specimen. Biopsies should be deep because the lesions are submucosal and the overlying mucosa may be thickened by reactive inflammato ry changes. Nevertheless, fine-needle aspiration cytolog y does have some use. For one, th e presence of abnorma l plasm a cells in a cytologic sample should raise th e suspicion of a plasma cell neoplasm . Moreover, aspiration cytology can be used to differentiate extr amedullary plasmacytoma from squamous cell carcinoma.
The appearance of plasmacytoma on histo logic examination may be similar to that of other small-cell tumors (e.g., melanoma, undifferentiated carcinoma, lymphoma,and pituitary adenoma) and benign inflammatory plasma cell tumors. Immunohistochemistr y differenti ates plasmacytoma from th ese other entities by exhibiting monoclonality and th e presence of kapp a or lambda light -chain-restricted immunoglobulins.Con go red staining may also reveal amyloid .
When there is no histo ry of plasma cell malignancy, it is crucial to exclude disseminated disease in the form of multiple myelom a.Such an investigation should includ e a complete blood cou nt , bon e ma rro w biopsy, urine and seru m electrophoresis, seru m bio chemistr y (including measurements of calcium, blo od ur ea nitrogen, creatinin e, uric acid, and protein ), and a skeletal survey to rul e out multiple myeloma. Other recommended investigation s include an immunoglobulin assay, measurement of CA125,Epstein-Barr virus testing , and MRI from th e skull base to the iliac crest.
Findings of normal bone marrow, an absence of lytic bone lesions on skeletal studies,and low paraprotein levels are necessary to establish th e diagnosis of extr am edullary plasmacytoma. High levels of parap rotein in th e urine or seru m should raise suspicion of dissem inated disease because parap rotein levels directly corre latewith tum or burden.
Extr amedull ary plasmacytoma can be staged as follows:
• stage I: localized and contro llable disease • stage II: local extensio n or involvement of lym ph nodes • stage III: disseminated disease Approximately 40% of extra medullary plasmacytomas spread beyond the sitewheretheyinitiallypresent and beyond the region drained by its local group of nodes. 9 Some 788' www.entjournal.com 62% of these occurre nces of distant spread are found in soft tissue and viscera (e.g., in the skin, liver, and subcutaneous tissues),and 81% are found as lesions in bone."
Th e tre atment of extramedullary plasmacyto-I ma involves radiotherapy and/or surg ery. Because extramedullary plasmacytoma is radiosensitive, radiotherapy is the treatment of choice." :" Surgery is the recommended mode of tre atment for tumor s th at arewell localized and can be excised completely.Radiotherapy and/ or surgery can also be used for salvage in cases of local recurrence. Chemoth erapy is used for disseminated disease.
A study of extrame dullary plasmacytom a with lon gterm follow-up showed th at local recurrence rat es were 21% with radiotherapy alon e, 20% with sur gery alone, and 46% with combined treatment." Th e high er recur rence rate following combined therapy may be explained by the fact th at th is mode of therapy was used in cases where the disease was more exten sive. Longterm follow-up is m andatory because recurrences have been reported as long as 28 and 36 years after primary tre atment." Patients with local recurrences are more likely to develop disseminated disease; approximatel y 35% of pati ents with extramedullary plasmacytoma progress to disseminated disease despite receiving initial treatment. 16 Between 17 and 31% of patient s diagnosed with extrame dullary plasmacytom a have developed mu ltiple myeloma."
In add ition to recurrence, factors th at contribute to a poor pro gnosis include bone destruction , a large pr imary tumo r, and a tumor location in th e sphenoid or maxillary sinus, orbit, or larynx. Hist ologic appearance and lymph node involvement have not been reported to affect the prognosis. Overall, the pr ogno sis is good provided th at multiple myelom a has been ruled OUt. 18 Kaplan-Maier survival estimates for plasmacytoma of th e head and neck show 95% survival at 1 year, 82% at 5 years, and 72% at 10 years."
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